Partnering with InnoCore

InnoCore actively exploits partnering and collaboration opportunities to complement its expertise and boost the innovation process. We continuously develop new sustained release products in partnership with pharma, biotech, medical device and academic institutions. In addition, InnoCore is always open to discuss in-licensing of new sustained release technologies.

Hence, we do believe in the power of partnerships that are based on mutual trust and recognize the added value of combining experience, know-how and competences. Different structures of license and development agreements are possible, depending on the partners’ needs and preferences.

 

Development and manufacturing

InnoCore has state-of-the-art facilities for polymer research, formulation development, analytical and manufacturing activities. Innovation is key in the services we provide to bring products from:

 

1. Exploratory feasibility

 

2. Feasibility

 

3. Optimization

 

​4. GLP tox batch

 

5. Scale up and optimization

 

6. GMP batch

 

InnoCore’s infrastructure enables support of partners not only during the first feasibility phase, but also during all subsequent product development phases, all the way up to manufacturing and supply of animal trial and clinical trial (GMP) batches and technology transfer if required. Regulatory support and quality assurance form an integral part of the product development services.

Over the past years, InnoCore has gathered extensive pre-clinical (including animal trials) data, allowing for an efficient and fast product development track. This in turn helps us realize, together with our partners, clinical trials in a timely manner.

 

Benefits of partnering with InnoCore

  1. Access to several patented drug delivery technologies
  2. Expertise in sustained release
  3. Full range of services in formulation, development and manufacturing
  4. Life cycle management